Psoriasis is a chronic, immune-mediated disease that includes a broad spectrum of systemic
manifestations, complications, and comorbidities. Approximately 20%–30% of patients with …

Psoriatic arthritis (PsA), a chronic inflammatory arthritis, affects about 10% of patients with
psoriasis with higher prevalence seen in patients with more extensive skin disease. Early …

Psoriatic arthritis is a common form of inflammatory arthritis that frequently accompanies
psoriasis of the skin—up to 30% of patients with psoriasis are affected. Recognition of the …

Objective To assess whether the presence of nonspecific musculoskeletal symptoms, their
degree, and change over time predict the development of psoriatic arthritis (PsA) in a …

It is unclear whether psoriasis is a progressive disease that requires early aggressive
intervention. This population-based study identified patients with psoriasis and psoriatic …

Psoriatic arthritis (PsA) is a chronic inflammatory disease that can be associated with
permanent joint damage and disability. Because patients may be unaware of the association …

Our understanding of psoriatic arthritis has evolved as new knowledge of the disease has
emerged. However, the exact prevalence of psoriatic arthritis is unknown, and its …

Dermatologists care for patients with psoriasis in whom there exists an inherent risk of
psoriatic arthritis, a condition with potential for causing joint damage and subsequent …

Early diagnosis of psoriatic arthritis (PsA) is essential for preventing disease progression
and joint destruction. The majority of patients develop PsA years after the onset of their skin …

Psoriatic arthritis (PsA) is an inflammatory arthritis that usually develops after the onset of
cutaneous psoriasis. Early diagnosis of PsA may lead to less joint damage and better long …